End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 […]
Tag: Robocath
Robocath successfully completes first robotic coronary angioplasty with R‑One in China
Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. The […]
Robocath and Rennes University Hospital launch co-development research program into treatment of strokes in partnership with Philips France
Rouen and Rennes, France, July 7, 2021 – Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke […]
Robocath successfully completes first robotic coronary angioplasties in Belgium
Rouen, France, May 4, 2021 – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of first five robotic coronary angioplasties in Belgium. The Percutaneous Coronary Interventions (PCI) were […]
Robocath finalizes creation of the joint venture with MicroPort through its medical robotic subsidiary MedBot
Rouen, France, November 2, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces creation of the joint venture with MicroPort Scientific Corporation ‘MicroPort’, through ‘MedBot’, its MicroPort MedBot […]
Robocath secures €40 million series C financing round to deploy its operations development plan
Rouen, France, April 29, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has secured €40 million ($43M) in a series C round of financing. This was led by […]
Robocath successfully completes first robotic coronary angioplasties in Africa
Rouen, France, December 16, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed six robotic coronary angioplasties with R-One™, a first for the continent of […]
Robocath strengthens its medical advisory board with international interventional cardiology experts
Rouen, France, May 21, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that Pr Haude, Dr Lorgat and Pr Nef have joined its medical advisory board. All are […]
Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform
100 percent technical success and no Major Adverse Cardiac Events (MACE) scored in first pre-clinical randomized trial Rouen, France, May 22, 2018 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces […]
Robocath Sets Up Medical Advisory Board Composed of International Interventional Cardiology Key Leaders
Rouen, January 30, 2018 – Robocath, a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases, announces today the creation of its medical advisory board, including global experts and recognized leaders in interventional cardiology. This committee will […]
